News
A new study published in the journal JAMA Otolaryngology–Head & Neck Surgery has found that deficits in the sense of smell, ...
Medicine to treat one thing may unintentionally help another -- but one vaccine is pulling triple duty for body, mind and ...
Experts Just Discovered That Alzheimer's Symptoms Can Surface In Your 20s And 30s. What To Watch For
The only actual available "test" for Alzheimer’s disease in younger people would be to check someone's APOE 4 levels, which ...
A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 RAs may help prevent the disease.
Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Over 6 million Americans are impacted by Alzheimer's disease, and researchers from Vanderbilt University Medical Center and the University of Pittsburgh are discovering how lifestyle habits can impact ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Are we promoting prevention strategies that work for everyone, or only for those who already have the means and access?
In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results